Fouad Atouf

Dec 3, 2024 | biopharminternational.com | Chris Spivey |Peter Marks |Fouad Atouf |Kenneth C. Chien |Constanze Blume

December 2, 2024By Standardization leading to CGT therapies becoming a standard of care. Importance to outcomes of high-quality starting materials, to reducing batch-to-batch quality, and the possibilities of allogeneic chimeric antigen receptor therapy (CAR-T) successes.

Jul 18, 2024 | biopharminternational.com | Chris Spivey |Peter Marks |Fouad Atouf |Kenneth C. Chien |Constanze Blume

Aligning mRNA Progress With Regulatory Streamlining - Episode 6Published on: , , , , SponsoredThe key to advancing mRNA therapeutics lies in developing more efficient and versatile delivery systems that can overcome challenges around stability, targeting, and safety. This discussion segment centered around the need for improved mRNA delivery systems to advance therapeutics.

Jul 18, 2024 | biopharminternational.com | Chris Spivey |Peter Marks |Fouad Atouf |Kenneth C. Chien |Constanze Blume

Aligning mRNA Progress With Regulatory Streamlining - Episode 5Published on: , , , , SponsoredThe discussion covers the challenges of optimizing mRNA therapies, including the diverse behaviors of mRNA in biological systems, as well as the opportunities presented by emerging mRNA technologies like circular and self-amplifying RNAs, and the role of regulators in ensuring quality control of these novel products.

Jul 18, 2024 | biopharminternational.com | Chris Spivey |Peter Marks |Fouad Atouf |Kenneth C. Chien |Constanze Blume

Aligning mRNA Progress With Regulatory Streamlining - Episode 7Published on: , , , , SponsoredThe panel highlights the need for continued research, collaboration between stakeholders, and a strategic approach to leveraging mRNA's capabilities to address unmet clinical needs. The panel discussed the current state of mRNA medicine, highlighting gaps in research and development, and the need for continued innovation to improve safety and efficacy.

Jul 18, 2024 | biopharminternational.com | Chris Spivey |Peter Marks |Fouad Atouf |Kenneth C. Chien |Constanze Blume

Aligning mRNA Progress With Regulatory Streamlining - Episode 3Published on: , , , , SponsoredThe panel discusses the rapid development of mRNA vaccines, the opportunities for mRNA technology to revolutionize drug discovery and gene therapy, and the need for regulatory collaboration to enable efficient review and access to these innovative treatments.